OTHER PROTEIN KINASE INHIBITORS IN ATC
- cabozantinib (cabozantinib malate) (CABOMETYX)
- capivasertib (TRUQAP)
- capmatinib (capmatinib hydrochloride) (TABRECTA)
- entrectinib (ROZLYTREK)
- gilteritinib (gilteritinib fumarate) (XOSPATA)
- larotrectinib (larotrectinib sulfate) (VITRAKVI)
- lenvatinib (lenvatinib mesylate) (LENVIMA)
- midostaurin (RYDAPT)
- nintedanib (nintedanib esilate) (OFEV)
- pazopanib (pazopanib hydrochloride) (VOTRIENT, PMS-PAZOPANIB)
- pralsetinib (GAVRETO)
- regorafenib (STIVARGA)
- ripretinib (QINLOCK)
- selpercatinib (RETEVMO)
- sorafenib (sorafenib tosylate) (NEXAVAR)
- sunitinib (SANDOZ SUNITINIB)
- sunitinib (sunitinib malate) (TEVA-SUNITINIB, AURO-SUNITINIB, SUTENT, TARO-SUNITINIB)
- tepotinib (tepotinib hydrochloride) (TEPMETKO)
- vandetanib (CAPRELSA)
Using Health Canada Drug Database
updated on 09May2024.